{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:34:13Z","timestamp":1758274453622,"version":"3.37.3"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["1115-844-67062"],"award-info":[{"award-number":["1115-844-67062"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022965","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["830-2019","2020-32092"],"award-info":[{"award-number":["830-2019","2020-32092"]}],"id":[{"id":"10.13039\/100022965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuropharm.2024.110152","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T10:24:53Z","timestamp":1725704693000},"page":"110152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Minocycline mitigates A\u03b2 and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"261","author":[{"given":"Daniela","family":"Giraldo-Berrio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3477-2386","authenticated-orcid":false,"given":"Marlene","family":"Jimenez-Del-Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0557-0411","authenticated-orcid":false,"given":"Carlos","family":"Velez-Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110152_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1474-4422(10)70323-9","article-title":"Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer\u2019s disease: a retrospective cohort study","volume":"10","author":"Acosta-Baena","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/07388551.2015.1128876","article-title":"Flow cytometry: basic principles and applications","volume":"37","author":"Adan","year":"2017","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib3","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s10787-022-01071-2","article-title":"Minocycline attenuates cholinergic dysfunction and neuro-inflammation-mediated cognitive impairment in scopolamine-induced Alzheimer\u2019s rat model","volume":"30","author":"Amirahmadi","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110152_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/biom14010011","article-title":"The potential of a stratified approach to drug repurposing in Alzheimer\u2019s disease","volume":"14","author":"Anderson","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2024.110152_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-319-18365-7_7","article-title":"The effect of (-)-Epigallo-catechin-(3)-gallate on amyloidogenic proteins suggests a common mechanism","volume":"863","author":"Andrich","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2019.112007","article-title":"CosIng database analysis and experimental studies to promote Latin American plant biodiversity for cosmetic use","volume":"144","author":"Bravo","year":"2020","journal-title":"Ind. Crops Prod."},{"key":"10.1016\/j.neuropharm.2024.110152_bib7","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00018-013-1550-7","article-title":"Neuronal calcium signaling: function and dysfunction","volume":"71","author":"Brini","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2024.110152_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00003495-197509040-00005","article-title":"Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use","volume":"9","author":"Brogden","year":"1975","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2024.110152_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/2398212818820506","article-title":"Acetylcholine and cholinergic receptors","volume":"3","author":"Brown","year":"2019","journal-title":"Brain Neurosci. Adv."},{"key":"10.1016\/j.neuropharm.2024.110152_bib10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3390\/biomedicines9101431","article-title":"A perspective on the development of c-Jun N-terminal kinase inhibitors as therapeutics for Alzheimer\u2019s disease: investigating structure through docking studies","volume":"9","author":"Cho","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2024.110152_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbrc.2009.06.026","article-title":"Minocycline attenuates iron neurotoxicity in cortical cell cultures","volume":"386","author":"Chen-Roetling","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2024.110152_bib12","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1021\/jm0506625","article-title":"Benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies","volume":"48","author":"Chu","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.110152_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.951","article-title":"Discriminating between apoptosis, necrosis, necroptosis, and ferroptosis by microscopy and flow cytometry","volume":"3","author":"Costigan","year":"2023","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.neuropharm.2024.110152_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnagi.2020.00220","article-title":"Decreased deposition of beta-amyloid 1-38 and increased deposition of beta-amyloid 1-42 in brain tissue of presenilin-1 E280A familial Alzheimer\u2019s disease patients","volume":"12","author":"Dinkel","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110152_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.sbi.2014.12.004","article-title":"Inhibition of protein aggregation and amyloid formation by small molecules","volume":"30","author":"Doig","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13452","article-title":"Minocycline alleviated scopolamine-induced amnesia by regulating antioxidant and cholinergic function","volume":"9","author":"Eshaghi Ghalibaf","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2024.110152_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/glia.20268","article-title":"Inhibitory effect of minocycline on amyloid \u03b2 fibril formation and human microglial activation","volume":"53","author":"Familian","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2024.110152_bib18","doi-asserted-by":"crossref","first-page":"19665","DOI":"10.1021\/acsomega.2c01412","article-title":"Inhibition mechanisms of (\u2212)-Epigallocatechin-3-gallate and genistein on amyloid-beta 42 peptide of Alzheimer\u2019s disease via molecular simulations","volume":"7","author":"Fang","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.neuropharm.2024.110152_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-2094-9-62","article-title":"Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer\u2019s disease-like amyloid pathology","volume":"9","author":"Ferretti","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2024.110152_bib20","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.3390\/ijms24098161","article-title":"Identification of catechins' binding sites in monomeric A\u03b242 through ensemble docking and MD simulations","volume":"24","author":"Firouzi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110152_bib21","volume":"63","author":"Flamm","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neuropharm.2024.110152_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101403","article-title":"Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene","volume":"35","author":"Frederiksen","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.neuropharm.2024.110152_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2017.03.010","article-title":"Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid \u03b2 (1-42) in mice","volume":"77","author":"Garcez","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.110152_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2012.10.006","article-title":"What is behind the non-antibiotic properties of minocycline?","volume":"67","author":"Garrido-Mesa","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2024.110152_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175784","article-title":"Minocycline effects on memory and learning impairment in the beta-amyloid-induced Alzheimer\u2019s disease model in male rats using behavioral, biochemical, and histological methods","volume":"953","author":"Gholami Mahmoudian","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.937133","article-title":"Neuronal cell death mechanisms in Alzheimer\u2019s disease: an insight","volume":"15","author":"Goel","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110152_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1257700","article-title":"Drug repurposing for Alzheimer\u2019s disease from 2012\u20132022\u2014a 10-year literature review","volume":"14","author":"Grabowska","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2010.10.004","article-title":"Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action","volume":"63","author":"Griffin","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2024.110152_bib30","first-page":"218","article-title":"Epigallocatechin 3-gallate as an inhibitor of tau phosphorylation and aggregation: a molecular and structural insight","volume":"4","author":"Gu\u00e9roux","year":"2017","journal-title":"J. Prevent. Alzheimer\u2019s Dise."},{"key":"10.1016\/j.neuropharm.2024.110152_bib31","doi-asserted-by":"crossref","DOI":"10.2142\/biophysico.bppb-v20.0007","article-title":"Molecular mechanisms of amyloid-\u03b2 peptide fibril and oligomer formation: NMR-based challenges","volume":"20","author":"Hiroaki","year":"2023","journal-title":"Biophys. Physicobiol."},{"issue":"14.38","key":"10.1016\/j.neuropharm.2024.110152_bib32","article-title":"Measuring apoptosis by microscopy and flow cytometry","volume":"112","author":"Hollville","year":"2016","journal-title":"Curr. Protoc. Im."},{"key":"10.1016\/j.neuropharm.2024.110152_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/eme07020","article-title":"Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer\u2019s disease: the MADE Phase II, three-arm RCT","volume":"7","author":"Howard","year":"2020","journal-title":"Efficacy Mech. Eval."},{"key":"10.1016\/j.neuropharm.2024.110152_bib34","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1074\/jbc.273.16.9357","article-title":"Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis","volume":"273","author":"J\u00e4nicke","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110152_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2016.10.013","article-title":"Physiological effects of epigallocatechin-3-gallate (EGCG) on energy expenditure for prospective fat oxidation in humans: a systematic review and meta-analysis","volume":"43","author":"Kapoor","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2024.110152_bib36","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbrc.2004.03.110","article-title":"Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells","volume":"317","author":"Kinumi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2024.110152_bib37","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1021\/acschemneuro.8b00182","article-title":"Structural basis of small molecule targetability of monomeric tau protein","volume":"9","author":"Kiss","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110152_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/bio.1339","article-title":"Evaluation of the antioxidant activity of tetracycline antibiotics in vitro","volume":"27","author":"K\u0142adna","year":"2012","journal-title":"Luminescence"},{"key":"10.1016\/j.neuropharm.2024.110152_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1471-4159.2005.03219.x","article-title":"Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical\u2010scavenging activity","volume":"94","author":"Kraus","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110152_bib40","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1016\/j.jalz.2013.09.005","article-title":"Origin of the PSEN1 E280A mutation causing early-onset Alzheimer\u2019s disease","volume":"10","author":"Lalli","year":"2014","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.neuropharm.2024.110152_bib41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/1567205016666190325092841","article-title":"Does intraneuronal accumulation of carboxyl-terminal fragments of the amyloid precursor protein trigger early neurotoxicity in Alzheimer\u2019s disease?","volume":"16","author":"Lauritzen","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2024.110152_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005282","article-title":"What exactly is \u2018N\u2019 in cell culture and animal experiments?","volume":"16","author":"Lazic","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib43","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.3390\/nu7075230","article-title":"Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome","volume":"7","author":"Legeay","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2024.110152_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10495-021-01667-z","article-title":"The role of P53 up-regulated modulator of apoptosis (PUMA) in ovarian development, cardiovascular and neurodegenerative diseases","volume":"26","author":"Li","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.neuropharm.2024.110152_bib45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","article-title":"Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"129","author":"Liu","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib46","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1073\/pnas.081553598","article-title":"\u03b2-Amyloid peptide blocks the response of \u03b17-containing nicotinic receptors on hippocampal neurons","volume":"98","author":"Liu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2024.110152_bib47","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2024.110152_bib48","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jama.1997.03540340027028","article-title":"Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation","volume":"277","author":"Lopera","year":"1997","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2024.110152_bib49","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/cpt1973145852","article-title":"Pharmacokinetic studies on minocycline in man","volume":"14","author":"Macdonald","year":"1973","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110152_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ncl.2017.01.005","article-title":"Early-onset Alzheimer disease","volume":"35","author":"Mendez","year":"2017","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neuropharm.2024.110152_bib51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneumeth.2018.11.019","article-title":"Direct transdifferentiation of human Wharton\u2019s jelly mesenchymal stromal cells into cholinergic-like neurons","volume":"312","author":"Mendivil-Perez","year":"2019","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2024.110152_bib52","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.3390\/ijms24108957","article-title":"PSEN1 E280A cholinergic-like neurons and cerebral spheroids derived from mesenchymal stromal cells and from induced pluripotent stem cells are neuropathologically equivalent","volume":"24","author":"Mendivil-Perez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110152_bib53","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.phytochem.2006.06.020","article-title":"Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives","volume":"67","author":"Nagle","year":"2006","journal-title":"Phytochemistry"},{"key":"10.1016\/j.neuropharm.2024.110152_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2017.06.018","article-title":"EGCG inhibits the oligomerization of amyloid beta (16-22) hexamer: theoretical studies","volume":"76","author":"Ngo","year":"2017","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.neuropharm.2024.110152_bib55","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1096\/fj.08-113795","article-title":"Minocycline reduces the development of abnormal tau species in models of Alzheimer\u2019s disease","volume":"23","author":"Noble","year":"2009","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2024.110152_bib56","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1021\/acs.jmedchem.2c00335","article-title":"Mechanistic insights for drug repurposing and the design of hybrid drugs for Alzheimer\u2019s disease","volume":"65","author":"Padhi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.110152_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.heares.2009.05.006","article-title":"Cytoplasmic Ca2+ concentration changes evoked by cholinergic stimulation in primary astrocyte cultures prepared from the rat cochlear nucleus","volume":"255","author":"Pap","year":"2009","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2024.110152_bib58","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2174\/156720501209151019104951","article-title":"Identification of small molecule inhibitors of tau aggregation by target-ing monomeric tau as a potential therapeutic approach for tauopathies","volume":"12","author":"Pickhardt","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2024.110152_bib59","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.3390\/molecules28114544","article-title":"Insights into the structural conformations of the tau protein in different aggregation status","volume":"28","author":"Pinzi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.110152_bib60","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/alz.12843","article-title":"A public resource of baseline data from the Alzheimer\u2019s prevention initiative autosomal\u2010dominant Alzheimer\u2019s disease trial","volume":"19","author":"Reiman","year":"2023","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.neuropharm.2024.110152_bib61","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1007\/s12035-023-03433-5","article-title":"A review on caspases: key regulators of biological activities and apoptosis","volume":"60","author":"Sahoo","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib62","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/ph14080732","article-title":"Exploring the early stages of the amyloid A\u03b2(1\u201342) peptide aggregation process: an NMR study","volume":"14","author":"Santoro","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2024.110152_bib63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature05695","article-title":"Atomic structures of amyloid cross-\u03b2 spines reveal varied steric zippers","volume":"447","author":"Sawaya","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110152_bib64","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1074\/jbc.M110.169565","article-title":"Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite","volume":"286","author":"Schildknecht","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110152_bib65","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-022-32951-4","article-title":"Structure-based discovery of small molecules that disaggregate Alzheimer\u2019s disease tissue derived tau fibrils in vitro","volume":"13","author":"Seidler","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2024.110152_bib66","doi-asserted-by":"crossref","first-page":"C1195","DOI":"10.1152\/ajpcell.00423.2008","article-title":"Acetylcholine induces Ca 2+signaling in chicken retinal pigmented epithelial cells during dedifferentiation","volume":"296","author":"Sekiguchi-Tonosaki","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01264-21","article-title":"Minocycline activity against unusual clinically significant gram-negative pathogens","volume":"65","author":"Shortridge","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neuropharm.2024.110152_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69429-6","article-title":"EGCG impedes human Tau aggregation and interacts with Tau","volume":"10","author":"Sonawane","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.110152_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132903","article-title":"Antioxidant activity, storage stability and in vitro release of epigallocatechin-3-gallate (EGCG) encapsulated in hordein nanoparticles","volume":"388","author":"Song","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.neuropharm.2024.110152_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221669","article-title":"Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer\u2019s disease reveal intraneuronal sAPP\u03b2 fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: therapeutic implications","volume":"15","author":"Soto-Mercado","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110152_bib71","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3390\/biom11121845","article-title":"(-)-Epigallocatechin-3-Gallate diminishes intra-and extracellular amyloid-induced cytotoxic effects on cholinergic-like neurons from familial Alzheimer\u2019s disease PSEN1 E280A","volume":"11","author":"Soto-Mercado","year":"2021","journal-title":"Biomolecules"},{"issue":"s1","key":"10.1016\/j.neuropharm.2024.110152_bib72","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3233\/JAD-220903","article-title":"Neuroprotective effect of combined treatment with epigallocatechin 3-gallate and melatonin on familial Alzheimer\u2019s disease PSEN1 E280A cerebral spheroids derived from menstrual mesenchymal stromal cells","volume":"99","author":"Soto-Mercado","year":"2024","journal-title":"J. Alzheim. Dis.: JAD"},{"key":"10.1016\/j.neuropharm.2024.110152_bib73","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0002-9440(10)65460-0","article-title":"Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer\u2019s disease","volume":"155","author":"Stadelmann","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib74","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0006-8993(01)02018-2","article-title":"Activated caspase-3 expression in Alzheimer\u2019s and aged control brain: correlation with Alzheimer pathology","volume":"898","author":"Su","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110152_bib75","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/pin.12520","article-title":"Plaque formation and the intraneuronal accumulation of \u03b2\u2010amyloid in Alzheimer\u2019s disease","volume":"67","author":"Takahashi","year":"2017","journal-title":"Pathol. Int."},{"key":"10.1016\/j.neuropharm.2024.110152_bib76","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/cells12030454","article-title":"The pursuit of the \u201cinside\u201d of the amyloid hypothesis\u2014is C99 a promising therapeutic target for Alzheimer\u2019s disease?","volume":"12","author":"Takasugi","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2024.110152_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-60799-9","article-title":"Basal forebrain volume and metabolism in carriers of the Colombian mutation for autosomal dominant Alzheimer\u2019s disease","volume":"14","author":"Teipel","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.110152_bib78","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","article-title":"Neuropathology of Alzheimer\u2019s disease","volume":"19","author":"Trejo-Lopez","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2024.110152_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101440","article-title":"Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer\u2019s Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene","volume":"37","author":"Vallejo-Diez","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.neuropharm.2024.110152_bib80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/ADR-220079","article-title":"The amyloid cascade hypothesis 2.0: generalization of the concept","volume":"7","author":"Volloch","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.neuropharm.2024.110152_bib81","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3233\/JAD-230164","article-title":"Effect of lecanemab and donanemab in early Alzheimer\u2019s disease: mechanistic interpretation in the amyloid cascade hypothesis 2.0 perspective","volume":"93","author":"Volloch","year":"2023","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2024.110152_bib82","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","article-title":"Assembly of \u03c4 protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK 311) forming \u03b2 structure","volume":"97","author":"von Bergen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2024.110152_bib83","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10930-021-10017-6","article-title":"The structure biology of tau and clue for aggregation inhibitor design","volume":"40","author":"Wang","year":"2021","journal-title":"Protein J."},{"key":"10.1016\/j.neuropharm.2024.110152_bib84","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer\u2019s disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110152_bib85","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1007\/s12035-023-03847-1","article-title":"Caspases in Alzheimer\u2019s disease: mechanism of activation, role, and potential treatment","volume":"61","author":"W\u00f3jcik","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1029473","article-title":"The function of p53 and its role in Alzheimer\u2019s and Parkinson\u2019s disease compared to age-related macular degeneration","volume":"16","author":"Wolfrum","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110152_bib87","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fphar.2015.00321","article-title":"c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer\u2019s disease","volume":"6","author":"Yarza","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110152_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.912995","article-title":"Mouse models of Alzheimer\u2019s disease","volume":"15","author":"Yokoyama","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110152_bib89","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/toxins14050339","article-title":"Variation in rotenone and deguelin contents among strains across four Tephrosia species and their activities against aphids and whiteflies","volume":"14","author":"Zhang","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.neuropharm.2024.110152_bib90","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2174\/1570159X19666211202124925","article-title":"Ameliorating Alzheimer\u2019s-like pathology by minocycline via inhibiting Cdk5\/p25 signaling","volume":"20","author":"Zhao","year":"2022","journal-title":"Curr. Neuropharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:57:15Z","timestamp":1730865435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":90,"alternative-id":["S0028390824003216"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110152","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minocycline mitigates A\u03b2 and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110152"}}